Daily Briefing

Charted: The risks of Covid-19—by age and vaccine brand


Unvaccinated people are significantly more likely to test positive for Covid-19 and to die from the disease than those who have been vaccinated, according to recent data released by CDC.

Your top resources on the Covid-19 vaccines

    Covid-19 risk by age, vaccine type

    CDC analyzed data from 16 public health departments, which includes information on roughly 30% of the U.S. population and covers the period from April through the end of August.

    Overall, CDC found that unvaccinated people are six times as likely to develop Covid-19 and 11 times as likely to die of the disease than those who are vaccinated.

    Age also remains a significant risk factor for severe cases of Covid-19. CDC found that vaccinated people who are ages 80 or higher are still at a higher risk of dying from Covid-19 than vaccinated or unvaccinated people under the age of 50.

    The data confirmed that all three vaccines that are authorized in the United States—manufactured by Johnson & Johnson (J&J), Moderna, and Pfizer-BioNTech—dramatically reduced both infections and deaths from Covid-19. The mRNA-based vaccines from Moderna and Pfizer-BioNTech appeared to provide the strongest protection.

    In a tweet, Celine Gounder, an infectious diseases expert at New York University, said CDC's data shows a "compelling" reason for allowing recipients of the J&J vaccine to receive an additional dose. (Carbajal, Becker's Hospital Review, 10/18; Owens, Axios, 10/19; Owens, Axios, 10/18; Sullivan, The Hill, 10/15)


    SPONSORED BY

    INTENDED AUDIENCE

    AFTER YOU READ THIS

    AUTHORS

    TOPICS

    MORE FROM TODAY'S DAILY BRIEFING

    Don't miss out on the latest Advisory Board insights

    Create your free account to access 2 resources each month, including the latest research and webinars.

    Want access without creating an account?

       

    You have 2 free members-only resources remaining this month remaining this month.

    1 free members-only resources remaining this month

    1 free members-only resources remaining this month

    You've reached your limit of free monthly insights

    Become a member to access all of Advisory Board's resources, events, and experts

    Never miss out on the latest innovative health care content tailored to you.

    Benefits include:

    Unlimited access to research and resources
    Member-only access to events and trainings
    Expert-led consultation and facilitation
    The latest content delivered to your inbox

    You've reached your limit of free monthly insights

    Become a member to access all of Advisory Board's resources, events, and experts

    Never miss out on the latest innovative health care content tailored to you.

    Benefits include:

    Unlimited access to research and resources
    Member-only access to events and trainings
    Expert-led consultation and facilitation
    The latest content delivered to your inbox
    AB
    Thank you! Your updates have been made successfully.
    Oh no! There was a problem with your request.
    Error in form submission. Please try again.